Contribution of individual components to composite end points in contemporary cardiovascular randomized controlled trials
- 1 December 2020
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 230, 71-81
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Survival Analysis and Interpretation of Time-to-Event Data: The Tortoise and the HareAnesthesia & Analgesia, 2018
- Understanding the Use of Composite Endpoints in Clinical TrialsWestern Journal of Emergency Medicine, 2018
- Composite End Points in Clinical ResearchCirculation, 2017
- How useful are randomized controlled trials in a rapidly changing world?Cambridge Prisms: Global Mental Health, 2016
- Composite outcome measures in a pragmatic clinical trial of chronic heart failure management: A comparative assessmentInternational Journal of Cardiology, 2015
- Individual and Composite Study Endpoints: Separating the Wheat from the ChaffThe American Journal of Medicine, 2014
- Addressing Multiplicity Issues of a Composite Endpoint and Its Components in Clinical TrialsJournal of Biopharmaceutical Statistics, 2011
- Key Issues in End Point Selection for Heart Failure Trials: Composite End PointsJournal of Cardiac Failure, 2005
- Composite Outcomes in Randomized TrialsJAMA, 2003
- Understanding controlled trials: Why are randomised controlled trials important?BMJ, 1998